Understanding brain damage in sickle cell disease using advanced MRI techniques
Probing silent cerebral infarct pathogenesis in sickle cell disease with cerebrovascular MRI
This study is looking at how we can better understand brain damage in children with sickle cell disease by using special MRI scans to see how well their blood vessels work, which could help us find ways to prevent and treat these issues earlier.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10903928 on NIH RePORTER |
What this research studies
This research investigates how silent cerebral infarcts, which are areas of brain damage in children with sickle cell disease, can be better understood using advanced MRI techniques. The study focuses on measuring cerebrovascular reactivity, which reflects how well blood vessels respond to changes in blood flow, providing insights into the vascular health of the brain. By using these MRI measurements, the research aims to identify risk factors for silent cerebral infarcts earlier than current methods, potentially leading to better prevention and treatment strategies for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with sickle cell disease who may be at risk for silent cerebral infarcts.
Not a fit: Patients without sickle cell disease or those who do not have silent cerebral infarcts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for preventing brain damage in children with sickle cell disease.
How similar studies have performed: Previous studies have shown that advanced MRI techniques can provide valuable insights into cerebrovascular health, indicating that this approach has potential for success.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Zvolanek, Kristina — Northwestern University at Chicago
- Study coordinator: Zvolanek, Kristina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.